Zacks upgraded shares of Sabra Healthcare REIT (NASDAQ:SBRA) from a neutral rating to an outperform rating in a research note issued to investors on Monday, American Banking News.com reports. The firm currently has $28.60 price target on the stock.
Zacks has also modified their ratings on a number of other financials stocks in the few days. The firm upgraded shares of Associated Estates Realty Corp. from an underperform rating to a neutral rating. The firm now has a $15.80 price target on that stock. Also, Zacks reiterated its neutral rating on shares of Weyerhaeuser Co.. They have a $33.00 price target on that stock. Finally, Zacks reiterated its neutral rating on shares of Simon Property Group Inc.. They have a $168.00 price target on that stock.
Shares of Sabra Healthcare REIT (NASDAQ:SBRA) traded down 0.04% during mid-day trading on Monday, hitting $27.32. 15,993 shares of the company’s stock traded hands. Sabra Healthcare REIT has a 52-week low of $19.54 and a 52-week high of $32.40. The stock’s 50-day moving average is $23.8 and its 200-day moving average is $27.15. The company has a market cap of $1.020 billion and a P/E ratio of 53.59.
Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings data on Wednesday, October 23rd. The company reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $32.90 million for the quarter, compared to the consensus estimate of $33.01 million. On average, analysts predict that Sabra Healthcare REIT will post $1.86 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, November 29th. Investors of record on Friday, November 15th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 4.98%. The ex-dividend date is Wednesday, November 13th.
SBRA has been the subject of a number of other recent research reports. Analysts at Jefferies Group raised their price target on shares of Sabra Healthcare REIT from $28.00 to $30.00 in a research note to investors on Friday, October 25th. They now have a buy rating on the stock. Finally, analysts at RBC Capital raised their price target on shares of Sabra Healthcare REIT from $31.00 to $33.00 in a research note to investors on Monday, August 5th. They now have an outperform rating on the stock. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The company currently has a consensus rating of Buy and an average price target of $29.72.
Sabra Health Care REIT, Inc (NASDAQ:SBRA) as a wholly owned subsidiary of Sun Healthcare Group, Inc, a provider of nursing, rehabilitative and related specialty healthcare services to the senior population in the United States.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.